SEARCH

SEARCH BY CITATION

REFERENCES

  • Albers S, Mir TS, Haddad M, Laer S. (2006) N-terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability. Clinical Chemistry and Laboratory Medicine 44:8085.
  • Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J, Schulte M, Von Wild K, Scherer R. (1997) Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 349:245249.
  • Buttner T, Lack B, Jager M, Wunsche W, Kuhn W, Muller T, Przuntek H, Postert T. (1999) Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures. Journal of Neurology 246:459461.
  • Chen DK, So YT, Fisher RS. (2005) Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 65:668675.
  • De Lemos JA, McGuire DK, Drazner MH. (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316322.
  • Franzoni MF, Canonaco M, Frova A, Tavolaro R. (1992) Brain natriuretic peptide (BNP)-like immunoreactivity in the central nervous system of the crested newt. European Journal of Histochemistry 36:455466.
  • Herring N, Zaman JA, Paterson DJ. (2001) Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. American Journal of Physiology. Heart and Circulatory Physiology 281:H2318H2327.
  • Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. (2005) N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293:16091616.
  • Levin ER, Gardner DG, Samson WK. (1998) Natriuretic peptides. The New England Journal of Medicine 339:321328.
  • Makikallio AM, Makikallio TH, Korpelainen JT, Vuolteenaho O, Tapanainen JM, Ylitalo K, Sotaniemi KA, Huikuri HV, Myllyla VV. (2005) Natriuretic peptides and mortality after stroke. Stroke 36:10161020.
  • Malkowicz DE, Legido A, Jackel RA, Sussman NM, Eskin BA, Harner RN. (1995) Prolactin secretion following repetitive seizures. Neurology 45:448452.
  • McMurray J, Davie AP, McClure SJ. (1998) Assessment of heart failure with plasma natriuretic peptides. Lancet 351:444; Author Reply 445.
  • Minamino N, Aburaya M, Ueda S, Kangawa K, Matsuo H. (1988) The presence of brain natriuretic peptide of 12,000 Daltons in porcine heart. Biochemical and Biophysical Research Communications 155:740746.
  • Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, Von Buelow H, Laer S, Weil J. (2003) Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112:896899.
  • Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J. (2002) Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110:e76.
  • Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. (2004) N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatrica 93:603607.
  • Obi T, Takatsu M, Konishi T, Mizoguchi K, Nishimura Y. (2002) Secretion of natriuretic peptides caused by an epileptic attack. Acta Neurologica Scandinavica 106:225228.
  • Perrone BL, Vari RC, Kreisman NR. (1995) Recurrent seizures alter renal function and plasma atrial natriuretic peptide levels in rats. Epilepsia 36:649657.
  • Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, Pahlman S. (1987) S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 18:911918.
  • Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Epilepsia 30:389399.
  • Protter AA, Wallace AM, Ferraris VA, Weishaar RE. (1996) Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. American Journal of Hypertension 9:432436.
  • Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG. (2003) B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107:27862792.
  • P-Codrea Tigaran S, Dalager-Pedersen S, Baandrup U, Dam M, Vesterby-Charles A. (2005) Sudden unexpected death in epilepsy: is death by seizures a cardiac disease? The American Journal of Forensic Medicine and Pathology 26:99105.
  • Sviri GE, Shik V, Raz B, Soustiel JF. (2003) Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochirurgica (Wien) 145:851860; Discussion 860.
  • Takahashi K, Totsune K, Sone M, Ohneda M, Murakami O, Itoi K, Mouri T. (1992) Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides 13:121123.
  • Tanabe T, Suzuki S, Hara K, Shimakawa S, Wakamiya E, Tamai H. (2001) Cerebrospinal fluid and serum neuron-specific enolase levels after febrile seizures. Epilepsia 42:504507.
  • Tigaran S, Molgaard H, McClelland R, Dam M, Jaffe AS. (2003) Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology 60:492495.
  • Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. The New England Journal of Medicine 350:655663.
  • Yang RH, Jin HK, Wyss JM, Chen YF, Oparil S. (1992) Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii. Hypertension 19:198205.
  • Zijlmans M, Flanagan D, Gotman J. (2002) Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia 43:847854.